Dolby Laboratories (DLB): Price and Financial Metrics
Dolby Laboratories (DLB)
Today's Latest Price: $53.94 USD
Updated Mar 27 12:00am
Add DLB to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 35 in Technology - Electronics
See all "A" rated Strong Buy stocks
DLB Stock Summary
- For DLB, its debt to operating expenses ratio is greater than that reported by only 12.98% of US equities we're observing.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.22 for Dolby Laboratories Inc; that's greater than it is for merely 13% of US stocks.
- In terms of volatility of its share price, DLB is more volatile than merely 7.62% of stocks we're observing.
- Stocks with similar financial metrics, market capitalization, and price volatility to Dolby Laboratories Inc are SINA, NTGR, CGNX, TRIP, and AZPN.
- Visit DLB's SEC page to see the company's official filings. To visit the company's web site, go to www.dolby.com.
DLB Stock Price Chart More Charts
DLB Price/Volume Stats
| Current price | $53.94 | 52-week high | $73.20 |
| Prev. close | $57.12 | 52-week low | $44.68 |
| Day low | $53.39 | Volume | 441,100 |
| Day high | $55.70 | Avg. volume | 481,467 |
| 50-day MA | $65.25 | Dividend yield | 1.63% |
| 200-day MA | $64.91 | Market Cap | 5.45B |
Dolby Laboratories (DLB) Company Bio
Dolby Laboratories creates audio, imaging, and communication technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company was founded in 1965 and is based in San Francisco, California.
DLB Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $53.94 | $11.97 | -79% |
We started the process of determining a valid price forecast for Dolby Laboratories Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Dolby Laboratories Inc ranked in the 14th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 78.83%. The most interesting components of our discounted cash flow analysis for Dolby Laboratories Inc ended up being:
- The company's compound free cash flow growth rate over the past 5.75 years comes in at -0.06%; that's greater than only 20.68% of US stocks we're applying DCF forecasting to.
- The business' balance sheet suggests that 1% of the company's capital is sourced from debt; this is greater than only 5.88% of the free cash flow producing stocks we're observing.
- The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Consumer Cyclical).
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -79% |
| 1% | -79% |
| 2% | -79% |
| 3% | -79% |
| 4% | -79% |
| 5% | -78% |
WBC, FOXF, VFC, WPP, and BXG can be thought of as valuation peers to DLB, in the sense that they are in the Consumer Cyclical sector and have a similar price forecast based on DCF valuation.
Loading social stream, please wait...